Variant report
Variant | nsv38978 |
---|---|
Chromosome Location | chr11:105049275-105051786 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs191115885 | chr11:105049375-105049376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs559367113 | chr11:105049397-105049398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs368457089 | chr11:105049409-105049410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs561657733 | chr11:105049424-105049425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs147362380 | chr11:105049427-105049428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs569072868 | chr11:105049450-105049451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs61893365 | chr11:105049493-105049494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs76288471 | chr11:105049506-105049507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563404679 | chr11:105049575-105049576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs182683740 | chr11:105049596-105049597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs557394175 | chr11:105049641-105049642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs552346604 | chr11:105049647-105049648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs112083231 | chr11:105049654-105049655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs528354940 | chr11:105049669-105049670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs372805130 | chr11:105049782-105049783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs546518954 | chr11:105049832-105049833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs11226651 | chr11:105049856-105049857 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs17103951 | chr11:105049892-105049893 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs550758903 | chr11:105049931-105049932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs115463482 | chr11:105049946-105049947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs116011816 | chr11:105049999-105050000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553187064 | chr11:105050044-105050045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558312777 | chr11:105050161-105050162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs201542549 | chr11:105050162-105050163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs573502913 | chr11:105050171-105050172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs377551301 | chr11:105050183-105050184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187808483 | chr11:105050201-105050202 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs556110692 | chr11:105050215-105050216 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs571011918 | chr11:105050239-105050240 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs146738025 | chr11:105050241-105050242 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs116888924 | chr11:105050244-105050245 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs192104367 | chr11:105050279-105050280 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs183364820 | chr11:105050291-105050292 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs575290284 | chr11:105050347-105050348 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs550313463 | chr11:105050379-105050380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs545614587 | chr11:105050392-105050393 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs373756035 | chr11:105050408-105050409 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs77821755 | chr11:105050453-105050454 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs568757634 | chr11:105050497-105050498 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs115753989 | chr11:105050515-105050516 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542038820 | chr11:105050535-105050536 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs561659734 | chr11:105050537-105050538 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs529228704 | chr11:105050559-105050560 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs375385997 | chr11:105050608-105050609 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550942052 | chr11:105050637-105050638 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs140407358 | chr11:105050664-105050665 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs368644008 | chr11:105050665-105050666 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs118004754 | chr11:105050674-105050675 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs369451245 | chr11:105050742-105050743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs375435696 | chr11:105050743-105050744 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Melanoma | 17363583 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Obesity | 19966786 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:105048600-105050200 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
2 | chr11:105048600-105052000 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr11:105048600-105052200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr11:105048600-105052200 | Weak transcription | NHLF | lung |
5 | chr11:105048600-105052400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
6 | chr11:105048600-105052400 | Weak transcription | NHDF-Ad | bronchial |
7 | chr11:105048800-105051800 | Weak transcription | NH-A | brain |
8 | chr11:105049000-105052200 | Weak transcription | Muscle Satellite Cultured Cells | -- |
9 | chr11:105049200-105052400 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
10 | chr11:105050200-105050800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
11 | chr11:105050200-105051000 | Enhancers | Fetal Heart | heart |
12 | chr11:105050200-105051000 | Enhancers | Fetal Intestine Small | intestine |
13 | chr11:105050200-105051000 | Enhancers | HepG2 | liver |
14 | chr11:105050200-105053000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
15 | chr11:105050200-105055000 | Enhancers | Primary monocytes fromperipheralblood | blood |
16 | chr11:105050800-105051000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
17 | chr11:105050800-105051000 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
18 | chr11:105050800-105051200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
19 | chr11:105051000-105051400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
20 | chr11:105051000-105052000 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
21 | chr11:105051000-105052000 | Weak transcription | Fetal Intestine Small | intestine |
22 | chr11:105051200-105051600 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
23 | chr11:105051400-105052000 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
24 | chr11:105051600-105052000 | Enhancers | Primary neutrophils fromperipheralblood | blood |